Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization
Ran Zhang(Anhui Medical University), Xiaobo Yu(Beijing Proteome Research Center), Youchun Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongye Wang(Guangzhou Experimental Station), Bingwei Wang(Nanjing University of Chinese Medicine), Xiaohan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Di Hu(Capital Medical University), Lan Huang(81th Hospital of PLA), Te Liang(Beihang University), Junyi Jiang(Beijing Proteome Research Center), Xiaomei Zhang(Tang Hospital), Yuanling Yu
Cited by 0
Related Papers
Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages
|Theranostics|2020|397
A new strategy for the fabrication of a flexible and highly sensitive capacitive pressure sensor
|Microsystems & Nanoengineering|2021|152
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
|Journal of Hematology & Oncology|2022|149
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
|Nature Communications|2021|146